CF related bone disease

C. Haworth (Cambridge, United Kingdom)

Source: ERS course 2015
Number: 19

PDF journal article, handout or slidesSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Haworth (Cambridge, United Kingdom). CF related bone disease. ERS course 2015

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The relationships between sarcopenia and decreased bone mineral density in each obstructive airway disease phenotype of Korea.
Source: International Congress 2017 – Clinical points to ponder in asthma
Year: 2017


Bone turnover markers, bone mineral density and body composition in Tunisian patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021


Loss of bone mineral density in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Primary care management of COPD
Year: 2007


Diagnosis and management of cystic fibrosis related low bone mineral density
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=150
Year: 2006

Plasma inflammatory markers associated with bone resorption in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008

Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor
Source: Eur Respir J 2005; 25: 54-61
Year: 2005



Resorptive-destructive processes of bone tissue in COPD patients
Source: International Congress 2019 – Asthma and COPD comorbidities
Year: 2019



Current status of research on osteoporosis in COPD: a systematic review
Source: Eur Respir J 2009; 34: 209-218
Year: 2009



Optical density of the bone and related parameters in adult patients with cystic fibrosis (CF)
Source: Eur Respir J 2007; 30: Suppl. 51, 388s
Year: 2007

DeltaF508 genotype for cystic fibrosis is significantly associated with reduced bone mineral density (BMD) in adults with CF
Source: Eur Respir J 2002; 20: Suppl. 38, 342s
Year: 2002

Biomarkers to predict decreased bone mineral density in patients with chronic respiratory failure
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


Biochemical markers of bone remodeling in children with chronic lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 262s
Year: 2006

Injection of bone marrow cells reduces bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2005 - In vivo - approaches to lung injury
Year: 2005


Serum leptin level may be a predictor of bone mineral loss in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 688s
Year: 2007

Clinical severity of chronic obstructive pulmonary disease is associated with bone mineral density
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015

Bone density in adult patients with cystic fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 265s
Year: 2002

Cystic fibrosis and bone disease: are we missing a genetic link?
Source: Eur Respir J 2005; 25: 9-11
Year: 2005


The bone metabolism in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 256s
Year: 2002

Bone mineral density in patients with chronic respiratory failure listed for transplantation
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent
Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019
Year: 2020